{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["66(8)"],"submitter":["Yarmolinsky J"],"funding":["BLRD VA","Cancer Research UK","World Health Organization","NCATS NIH HHS","NCCDPHP CDC HHS","NIA NIH HHS","NHLBI NIH HHS","World Cancer Research Fund","NIDDK NIH HHS","Medical Research Council","Diabetes UK","VA Office of R&D","National Institute for Health Research (NIHR)","NCI NIH HHS","NIH HHS","WHI NIH HHS"],"journal":["Diabetologia"],"pagination":["1481-1500"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10317892"],"repository":["biostudies-literature"],"pubmed_title":["Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis."],"pmcid":["PMC10317892"],"funding_grant_id":["U01 CA137088","K05 CA154337","C68933/A28534","K05 CA152715","28534","KL2 TR000421","17/0005587","BRC-1215-20011","U58 DP002333","R21 CA191312","R01 DK134575","IIG_2019_2009","R01 CA076366","HHSN268201100001C","P30 CA006973","I01-BX003362","U01 CA122839","R01 CA207371","R01 CA081488","001","I01 BX003362","MR/M012190/1","UM1 DK126194","MR/N013794/1","HHSN268201100002C","HHSN268201100046C","U01 CA086308","U01 CA167551","HHSN268201100003C","HHSN261201700006I","HHSN268201200008I","C18281/A29019","S10 OD028685","R01 CA114347","R01 CA097325","R01 CA059045","NIHR202411","U01 CA164930","R01 CA201407","U19 CA148107","P30 CA015704","U24 CA074794","29019","U01 CA206110","HHSN268201100004C","29017","R03 CA153323","HHSN271201100004C","U01 AG018033"],"pubmed_authors":["Vujkovic M","Berndt SI","Schoen RE","Koutros S","Burrows K","Pashayan N","Chang KM","Neal DE","Wolk A","Eeles RA","Hampe J","Claessens F","Razack A","Stanford JL","Mucci LA","Lessel D","Al Olama AA","Brenner H","Neuhausen SL","Roobol MJ","Travis RC","Blot WJ","Voight BF","Usmani N","Kibel AS","Vega A","Kim J","Khaw KT","Cannon-Albright L","Bull CJ","Gallinger S","West CML","Bouras E","John EM","Riboli E","Dimopoulou O","Schleutker J","Kogevinas M","De Ruyck K","PRACTICAL consortium","Albanes D","Lewis SJ","Moreno V","Batra J","Stevens VL","Hamilton RJ","Penney KL","Hamdy FC","Cybulski C","Gill D","Clements JA","VA Million Veteran Program","Schumacher FR","Teixeira MR","Lu YJ","Pharoah PDP","Rosenstein BS","Grindedal EM","Nordestgaard BG","Vincent EE","Wiklund F","Cancel-Tassin G","Gunter MJ","Benlloch S","Wang Y","Kote-Jarai Z","Ingles SA","Donovan JL","Tsao PS","Pellatt AJ","Tsilidis KK","Nielsen SF","Thibodeau SN","Martin RM","Kraft P","Constantinescu A","Tangen CM","Sorensen KD","Chanock S","Yarmolinsky J","Hunter DJ","Park JY","Newcomb LF","Giles GG","Muir K","Haiman CA","Townsend PA","Pandha H","Pai RK","Menegaux F","Gronberg H","Weinstein S","Conti DV","Jenkins MA","Maier C","Castelao JE","Kaneva R"],"additional_accession":[]},"is_claimable":false,"name":"Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Aug","modification":"2026-05-29T14:06:16.879Z","creation":"2025-02-19T03:20:58.714Z"},"accession":"S-EPMC10317892","cross_references":{"pubmed":["37171501"],"doi":["10.1007/s00125-023-05925-4"]}}